Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05897710 · ClinicalTrials.gov registry record · NA

Virtual World-Based Cardiac Rehabilitation

A NA study of Cardiovascular Diseases and Telemedicine, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
2,881
Enrollment target
1
Study location

NCT05897710 is a NA study of Cardiovascular Diseases and Telemedicine that has completed, run by Mayo Clinic. The registered enrollment target is 2,881 participants, below the 26,965-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05897710, a NA study of Cardiovascular Diseases and Telemedicine, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
2,881 participants
Enrollment target
1
Study location

Study Summary

The proposed trial is a multiphase, multicenter, non-inferiority, hybrid type 1 effectiveness, randomized controlled trial to test an innovative virtual world-based cardiac rehabilitation (CR) program, "Destination Cardiac Rehab". The primary objectives of this study are to assess the efficacy and adherence of "Destination Cardiac Rehab" compared to traditional center-based CR.

Interventions

  • OTHER Virtual World-Based Cardiac Rehabilitation (VWCR)
  • OTHER Center-Based Cardiac Rehabilitation (CBCR)

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 2,881 participants
Start Date 2023-03-07
Est. Completion 2024-01-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05897710

The ClinicalTrials.gov registry entry for NCT05897710 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,881 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,965-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (89% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Virtual World-Based Cardiac Rehabilitation (VWCR) is the first listed.

NCT05897710 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05897710 about?

NCT05897710 is a clinical study titled "Virtual World-Based Cardiac Rehabilitation". The proposed trial is a multiphase, multicenter, non-inferiority, hybrid type 1 effectiveness, randomized controlled trial to test an innovative virtual world-based cardiac rehabilitation (CR) program, "Destination Cardiac Rehab". The primary objectives of this study are to assess the efficacy and a...

What is the current status of trial NCT05897710?

This trial is currently completed. It is a NA study. The enrollment target is 2,881 participants. The study started on 2023-03-07. Estimated completion is 2024-01-31.

What conditions does trial NCT05897710 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Telemedicine, Cardiac Event.

What interventions are being tested in trial NCT05897710?

The interventions under investigation include: Virtual World-Based Cardiac Rehabilitation (VWCR) (OTHER), Center-Based Cardiac Rehabilitation (CBCR) (OTHER).

Who is sponsoring clinical trial NCT05897710?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05897710 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.